We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Medical Monitors Benefit from Developmental Synergies with Semiconductor Industry

By HospiMedica International staff writers
Posted on 08 Oct 2012
The evolution of semiconductors, which form an essential element in many patient monitoring systems, is being driven by the need for smaller, faster, and more advanced devices. More...
These are the latest findings of GBI Research (London, United Kingdom), a market-leading provider of business intelligence reports.

Patient monitoring devices can track an individual’s blood pressure (BP), temperature, oxygen-saturation (SpO2), or respiration, and can also offer data conversion, processing, and controlling. Todo so, they use embedded semiconductors such as thin-film capacitors, resistors and substrate technologies, System-in-Package (SiP) integrated chip (IC) technology, as well as high-energy batteries, all of which are critically important for patient monitoring devices. The sale of semiconductors therefore increases as the demand for patient monitoring devices climbs.

The reverse is also true; developments in semiconductor technologies also mean leaps and bounds in progress for patient monitoring abilities, since small and portable patient monitoring devices represent an improvement in a patient’s quality of life, allow monitoring and treatment to be conducted in more convenient locations – at home or elsewhere. Semiconductor components are therefore steadily shrinking to meet this need, becoming more compact in order to downsize the monitoring equipment.

The miniaturization of patient monitoring devices via cutting-edge semiconductor technology opens the possibility of mounting equipment within mobile clinics, ambulances, and doctors’ offices. This in turn will is expected to lead to an increasing number of applications available in the various patient monitoring devices, such as fetal monitors, neonatal monitors, multiparameter patient monitoring, remote patient monitoring, and BP monitors. Application availability will further drive the already growing demand for telehealth monitoring services and wireless devices.

GBI Research therefore expects the market for semiconductors in patient monitoring devices to grow at a high rate over the next few years, from USD 1.8 billion in 2011 to USD 2.4 billion by 2015. The global market is expected to change significantly, with developing countries in Asia-Pacific emerging as a powerful rival to the matured market in North America.

Related Links:

GBI Research



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.